HIGHLIGHTS
- who: Aleksandra Paterek and colleagues from the Department of Clinical Physiology, Centre of, , Department of Immunology, of, , Poland have published the article: Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma, in the Journal: (JOURNAL) of 27/03/2023
- what: Bortezomib exacerbates MM(Directive 2010/63/EU) and Polish (Dz.
SUMMARY
Oxide system. An arginase inhibitor protected the heart against bortezomib- or multiple myeloma-induced toxicity but did not completely prevent the effects of the multiple myeloma+bortezomib combination. MM resulted in All experiments were(LV) performed in 8-12-week . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.